<DOC>
	<DOCNO>NCT03068481</DOCNO>
	<brief_summary>The purpose study healthy adult male investigate safety pharmacokinetics single multiple oral dos KDT-3594 . The purpose study patient Parkinson 's disease investigate safety pharmacokinetics single multiple oral dos KDT-3594 . The exploratory efficacy KDT-3594 also investigate .</brief_summary>
	<brief_title>A Phase I Clinical Study KDT-3594 Healthy Adult Males Patients With Parkinson 's Disease .</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>Healthy volunteer part Healthy Japanese male age 20 35 year , inclusive Patient part Patients diagnose Parkinson 's disease accord UK Parkinson 's Disease society brain bank clinical diagnostic criterion Patients Parkinson 's disease Stages 1 3 Modified Hoehn Yahr Scale Male patient Parkinson 's disease age 20 74 year inclusive , postmenopausal female patient Parkinson 's disease age 50 74 year inclusive Healthy volunteer part Subjects abnormal finding physical examination vital sign , 12lead ECG , clinical laboratory test , ophthalmic examination electroencephalography Patient part Patients suspect parkinsonism except idiopathic Parkinson 's disease Healthy volunteer part patient part Subjects agree avoid dangerous work drive , mechanical operation highplace work completion followup examination</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>